Massachusetts negotiates HCV discounts

MassHealth, Massachusetts' state Medicaid program, said drug makers Gilead Sciences Inc. (NASDAQ:GILD) and Bristol-Myers Squibb Co. (NYSE:BMY) agreed to provide rebates that would give all MassHealth members access to HCV drugs

Read the full 314 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE